Cytocom, Inc. CBLI
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 226.39M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.08
- Inst. own
- 4.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 16, 2021
- 50-d avg
- 3.62
- 200-d avg
- 3.62
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for CBLI has not been loaded yet. Try again in a moment.
Altman Z-Score
435.14 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -18.2×
P/S 163×
P/B 21.2×
P/FCF -18.0×
EV/EBITDA -17.1×
EV/Sales 155×
FCF Yield -5.5%
Gross Margin 100.0%
Operating Margin -983.7%
Net Margin -912.2%
ROE -119.1%
ROIC -55.6%
ROA -103.5%
Revenue -76.4%
Operating Income -9.6%
EPS (diluted) 17.4%
Free Cash Flow 11.0%
Current Ratio 7.6×
Quick Ratio 7.6×
Debt / Equity 0.0×
Net Debt / EBITDA 0.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2020-12-31